期刊
CANCER MANAGEMENT AND RESEARCH
卷 13, 期 -, 页码 6141-6155出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/CMAR.S312621
关键词
TNRC6C-AS1; THCA; proliferation; migration; viability
类别
TNRC6C-AS1 regulates the expression of LPAR5 by competitively adsorbing miR-513c-5p, impacting the progression of thyroid cancer. This novel signaling pathway may serve as a potential target for cancer therapy.
Background: Considering the combined role of long non-coding RNA (lncRNAs)microRNA (miRNA)-mRNA in tumorigenesis, the purpose of this study was to investigate how TNRC6C-AS1 regulates the expression of lysophosphatidic acid receptor 5 (LPAR5) by modulating miR-513c-5p, thus influencing the progression of thyroid cancer (THCA). Methods: qRT-PCR and Western blotting were performed to detect the expression levels of TNRC6C-AS1, miR-513c-5p, and LPAR5 in THCA tissues and cell lines. The viability, proliferation, migration, and invasion were assessed using CCK-8, BrdU, wound healing, and transwell migration assays, respectively. Dual-luciferase reporter assay, RIP assay, and RNA pull-down assay were used to evaluate the relationship between TNRC6C-AS1, miR-513c5p, and LPAR5. Results: TNRC6C-AS1 was highly expressed in THCA tissues, and knockout of TNRC6CAS1 reduced the viability, proliferation, migration, and invasion of THCA cells. TNRC6C-AS1 competitively adsorbed miR-513c-5p. In addition, the biological function of TNRC6C-AS1 was blocked by knocking down the thyroid cell line TNRC6C-AS1 with miR-513c-5p inhibitor transfection. LPAR5 is the target gene for miR-513c-5p, which has the ability to eliminate the influence of miR-513c-5p on THCA cells. Conclusion: The TNRC6C-AS1/miR-513c-5p/LPAR5 axis is a novel signaling pathway that modulates THCA progression and may be a potential target for cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据